36.34
Pacira Biosciences Inc (PCRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
8.47%
192.40
|
177.38 | 196.87 | 179.52 | 181.10 |
| Cost Of Revenue |
21.29%
44.16
|
36.41 | 40.30 | 34.28 | 40.87 |
|
|
2.27%
91.81
|
93.94 | - | - | - |
| Costs And Expenses |
10.36%
188.13
|
170.47 | 194.53 | 173.15 | 172.60 |
| Operating Income/Loss |
38.18%
4.267
|
6.902 | 2.34 | 6.362 | 8.499 |
| Nonoperating Income/Loss |
10.08%
-1.712
|
-1.904 | -1.769 | 3.162 | -10.43 |
| Income/Loss From Continuing Operations Before Tax |
48.88%
2.555
|
4.998 | 0.571 | 9.524 | -1.927 |
| Income Tax Expense/Benefit |
200.77%
-2.098
|
2.082 | -1.066 | 4.092 | 2.92 |
| Net Income/Loss |
59.57%
4.653
|
2.916 | 1.637 | 5.432 | -4.847 |
| Basic Average Shares |
2.47%
39.46
|
40.46 | -0.691 | 44.04 | 45.46 |
| Diluted Average Shares |
1.49%
40.30
|
40.91 | -0.687 | 44.46 | 45.46 |
| Basic Earnings Per Share |
71.43%
0.12
|
0.07 | 0.04 | 0.12 | -0.11 |
| Diluted Earnings Per Share |
71.43%
0.12
|
0.07 | 0.04 | 0.12 | -0.11 |
자본화:
|
볼륨(24시간):